Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Mar 16:14:1146027.
doi: 10.3389/fneur.2023.1146027. eCollection 2023.

Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies

Joseph R Berger  1 , Hans-Peter Hartung  2   3   4
Affiliations
Comment

Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies

Joseph R Berger et al. Front Neurol. .
No abstract available

Keywords: immunogenetics; multiple sclerosis; natalizumab; progressive multifocal leucoencephalopathy (PML); risk factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

References

    1. Cortese I, Reich DS, Nath A. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol. (2021) 17:37–51. 10.1038/s41582-020-00427-y - DOI - PMC - PubMed
    1. Major EO, Yousry TA, Clifford DB. Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned. Lancet Neurol. (2018) 17:467–80. 10.1016/S1474-4422(18)30040-1 - DOI - PubMed
    1. Eis PS, Bruno CD, Richmond TA, Koralnik IJ, Hanson BA, Major EO, et al. . Germline genetic risk variants for progressive multifocal leukoencephalopathy. Front Neurol. (2020) 11:186. 10.3389/fneur.2020.00186 - DOI - PMC - PubMed
    1. Hatchwell E, Smith EB, III, Jalilzadeh S, Bruno CD, Taoufik Y, Hendel-Chavez H, et al. . Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies. Front Neurol. (2022) 13:1016377. 10.3389/fneur.2022.1016377 - DOI - PMC - PubMed
    1. Hamosh A. T-lymphocyte Surface Antigen LY-9; Ly9. Washington, DC: National Center for Biotechnology Information; (2022). Available online at: https://www.omim.org/entry/600684

LinkOut - more resources